Videos

New Clinical Trial Data Presented at ASCO 2018: How Will it Change How you Practice?

New Clinical Trial Data Presented at ASCO 2018: How Will it Change How you Practice?

FEATURING:

Dr David Spigel

July 25, 2018

ASCO 2018 Insights

CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer

CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer

FEATURING:

Dr Matthew Goetz

January 10, 2018

Breast Cancer, SABCS Highlights

Questions About Treating Patients Using a CDK4/6 Inhibitor

Questions About Treating Patients Using a CDK4/6 Inhibitor

FEATURING:

Dr Matthew Goetz

January 10, 2018

Breast Cancer, SABCS Highlights

Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?

Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?

FEATURING:

Dr Matthew Goetz

January 10, 2018

Breast Cancer, SABCS Highlights

The Use of Chemotherapy in the Metastatic Setting

The Use of Chemotherapy in the Metastatic Setting

FEATURING:

Dr Matthew Goetz

January 10, 2018

Breast Cancer, SABCS Highlights

The Mechanism of Action of CDK4/6 Inhibitors

The Mechanism of Action of CDK4/6 Inhibitors

FEATURING:

Dr Matthew Goetz

January 10, 2018

Breast Cancer, SABCS Highlights

HER2-Positive Breast Cancer and CDK4/6 Inhibitors

HER2-Positive Breast Cancer and CDK4/6 Inhibitors

FEATURING:

January 10, 2018

Breast Cancer, SABCS Highlights

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor

FEATURING:

January 10, 2018

Breast Cancer, SABCS Highlights

What Differentiates Abemaciclib, Ribociclib, and Palbociclib?

What Differentiates Abemaciclib, Ribociclib, and Palbociclib?

FEATURING:

January 10, 2018

Breast Cancer, SABCS Highlights

CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer

CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer

FEATURING:

January 10, 2018

Breast Cancer, SABCS Highlights

Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer

Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer

FEATURING:

January 10, 2018

Breast Cancer, SABCS Highlights

Hot Topics at SABCS 2017

Hot Topics at SABCS 2017

FEATURING:

January 10, 2018

Breast Cancer, SABCS Highlights

Left- vs Right-Sided Colon Cancers

Left- vs Right-Sided Colon Cancers

FEATURING:

Eric Van Cutsem, MD

July 14, 2017

Perspectives on Carcinoid Syndrome (CS) Diarrhea

Perspectives on Carcinoid Syndrome (CS) Diarrhea

FEATURING:

June 13, 2017

Challenges in Managing Toxicities

Challenges in Managing Toxicities

FEATURING:

Dr. Edward Garon

April 27, 2017

Lung Cancer, WCLC 2016 – Lung Cancer

Page 7 of 13

2
3
4
5
6
7
8
9
10
11

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

VBCC Print Edition

VBCC Weekly e‑Newsletter

I have reviewed and consent to the terms of VBCC's Privacy Policy, and VBCC has my permission to retain my information in its database, and to forward pertinent communications to me.